SARS-CoV-2 Envelope Protein Polyklonaler Antikörper

SARS-CoV-2 Envelope Protein Polyklonal Antikörper für ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Virus und mehr (1)

Anwendung

IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 28904-1-AP

Synonyme

COV19, COV-19, COVID19, COVID-19 E protein, E Protein, envelope protein, SARS-COV-2 E Protein, SARS-CoV-2 Envelope Protein



Geprüfte Anwendungen

Erfolgreiche Detektion in ELISARecombinant protein

Empfohlene Verdünnung

AnwendungVerdünnung
Enzyme-linked Immunosorbent Assay (ELISA)ELISA :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

IFSee 1 publications below

Produktinformation

28904-1-AP bindet in IF, ELISA SARS-CoV-2 Envelope Protein und zeigt Reaktivität mit Virus

Getestete Reaktivität Virus
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen SARS-CoV-2 Envelope Protein fusion protein Ag30690
Vollständiger Name COVID-19 E Protein
GenBank-ZugangsnummerNC_045512
Gene symbol COVID-19 E Protein
Gene ID (NCBI) 43740570
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenStore at -20°C. Stable for one year after shipment. Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).

Publikationen

SpeciesApplicationTitle
humanIF

Front Cell Neurosci

The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model

Authors - Jiahang Ju